Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates.
This manuscript is intended to provide a comprehensive review of the alpha-adrenoceptors (ARs) and their role in vascular regulation. The historical development of the concept of receptors and the division of the alpha-ARs into alpha 1 and alpha 2 subtypes is traced. Emphasis will be placed on current understanding of the specific contribution of discrete alpha 1- and alpha 2-AR subtypes in the regulation of the vasculature, selective agonists and antagonists for these receptors, the second messengers utilized by these receptors, the myoplasmic calcium pathways activated to initiate smooth muscle contraction, as well as the clinical uses of agonists and antagonists that work at these receptors. New information is presented that deals with the molecular aspects of ligand interactions with specific subdomains of these receptors, as well as mRNA distribution and the regulation of alpha 1- and alpha 2-AR gene transcription and translation.
Piascik
M T
MT
Department of Pharmacology, University of Kentucky College of Medicine, Lexington 40536, USA.
Soltis
E E
EE
Piascik
M M
MM
Macmillan
L B
LB
D003001:Cloning, Molecular; D019204:GTP-Binding Proteins / Q000378:metabolism; D006801:Humans; D009129:Muscle Tonus; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D011485:Protein Binding; D011942:Receptors, Adrenergic, alpha / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D015290:Second Messenger Systems; D015398:Signal Transduction
D011942:Receptors, Adrenergic, alpha; D019204:GTP-Binding Proteins